Osteopontin and splice variant expression level in human malignant glioma: Radiobiologic effects and prognosis after radiotherapy

Radiotherapy and Oncology

Volumn 108, Issue 3, 2013, Pages 535-540

  Güttler, Antje ^a   Giebler, Maria ^a   Cuno, Peter ^a   Wichmann, Henri ^a   Keßler, Jacqueline ^a   Ostheimer, Christian ^a   Söling, Ariane ^b   Strauss, Christian ^a   Illert, Jörg ^a   Kappler, Matthias ^a   Vordermark, Dirk ^a   Bache, Matthias ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Gliomas; Osteopontin; Radiation; Splice variants

Indexed keywords

MESSENGER RNA; OSTEOPONTIN; SMALL INTERFERING RNA;

ADULT; AGED; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CLONOGENIC ASSAY; CONTROLLED STUDY; FEMALE; GENE SILENCING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

GLIOMAS; OSTEOPONTIN; RADIATION; SPLICE VARIANTS;

BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOMA; HUMANS; OSTEOPONTIN; PROGNOSIS; RADIOBIOLOGY; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84887021060     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.06.036     Document Type: Article

References (20)

1. H.M. Said, C. Hagemann, and A. Staab Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo Radiother Oncol 83 2007 398 405
2. P. Sreekanthreddy, H. Srinivasan, and D.M. Kumar Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis Cancer Epidemiol Biomarkers Prev 19 2010 1409 1422
3. M. Bache, M. Kappler, and H. Wichmann Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients BMC Cancer 10 2010 132
4. O.P. Erpolat, P.U. Gocun, M. Akmansu, G. Ozgun, and G. Akyol Hypoxia-related molecules HIF-1alpha, CA9, and osteopontin: predictors of survival in patients with high-grade glioma Strahlenther Onkol 189 2013 147 154
5. H. Rangaswami, A. Bulbule, and G.C. Kundu Osteopontin: role in cell signaling and cancer progression Trends Cell Biol 16 2006 79 87
6. M.F. Young, J.M. Kerr, and J.D. Termine CDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN) Genomics 7 1990 491 502
7. A.J. Ward, and T.A. Cooper The pathobiology of splicing J Pathol 220 2010 152 163
8. E.R. Gimba, and T.M. Tilli Human osteopontin splicing isoforms: known roles, potential clinical applications and activated signaling pathways Cancer Lett 331 2013 11 17
9. A. Hahnel, H. Wichmann, and M. Kappler Effects of osteopontin inhibition on radiosensitivity of MDA-MB-231 breast cancer cells Radiat Oncol 5 2010 82
10. A. Soling, E.M. Plugge, and M. Schmitz Autoantibodies to the inhibitor of apoptosis protein survivin in patients with brain tumors Int J Oncol 30 2007 123 128
11. M. Mirza, E. Shaughnessy, and J.K. Hurley Osteopontin-c is a selective marker of breast cancer Int J Cancer 122 2008 889 897
12. W. Yan, C. Qian, and P. Zhao Expression pattern of osteopontin splice variants and its functions on cell apoptosis and invasion in glioma cells Neuro Oncol 12 2010 765 775
13. T.M. Tilli, K.D. Mello, and L.B. Ferreira Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells Prostate 72 2012 1688 1699
14. X. Tang, J. Li, and B. Yu Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancer Int J Biol Sci 9 2013 55 66
15. S. Chae, H.O. Jun, and E.G. Lee Osteopontin splice variants differentially modulate the migratory activity of hepatocellular carcinoma cell lines Int J Oncol 35 2009 1409 1416
16. J. Cheng, D.H. Huo, D.M. Kuang, J. Yang, L. Zheng, and S.M. Zhuang Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells Cancer Res 67 2007 5141 5147
17. A. Junaid, M.C. Moon, G.E. Harding, and P. Zahradka Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1 Am J Physiol Cell Physiol 292 2007 C919 C926
18. M. Bache, R. Reddemann, and H.M. Said Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels Int J Radiat Oncol Biol Phys 66 2006 1481 1487
19. M. Bache, M. Kappler, H.M. Said, A. Staab, and D. Vordermark Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies Curr Med Chem 15 2008 322 338
20. J. Overgaard, J.G. Eriksen, M. Nordsmark, J. Alsner, and M.R. Horsman Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial Lancet Oncol 6 2005 757 764